Paxlovid for Covid? @NEJMgroup
Paxlovid for Covid? @NEJMgroup
Uploaded May 2026 | Updated September 2026, 1 week ago
NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains new research published in NEJM on the effectiveness of nirmatrelvir–ritonavir in persons who have been vaccinated, infected naturally, or both. Read the full summary clinician.nejm.org.
Paxlovid for Covid?Image Challenge — August 6, 2026Spinal Epidural Abscess — Key Points in 90 SecondsImage Challenge | July 9, 2026Perspective Video Interview: Benchmarks for AI Agents and Medical TraineesNEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to ...Image Challenge — July 16, 2026NEJM This Week — April 23, 2026NEJM Interview: Deirdre Tobias on the 2025–2030 Dietary Guidelines for Americans, including areas...Case Record of the MGH: Cardiac Imaging in a Patient with Chest Pain and DyspneaNEJM Clinician: Catheter-Directed PE Treatment: Does it Deliver?Image Challenge — June 4, 2026
NEJM Group |

Paxlovid for Covid?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER